FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

FDA Posts Bioequivalence Recommendations

03/09/2015

Federal Register Notice: FDA is making available additional draft and revised draft product-specific bioequivalence (BE) recommend...

Workshop on Companion Diagnostics for Targeted Therapies

03/09/2015

Federal Register Notice: FDA will co-sponsor with the American Association for Cancer Research and the American Society of Clinica...

Comments Extended on Drug/Biologic Electronic Prescribing Info

03/09/2015

Federal Register Proposed rule: FDA is extending the comment period until 5/18 for the proposed rule that appeared in the 12/18/14...

Info on Blood CGMPs Sent to OMB

03/03/2015

Federal Register Notice: FDA’s proposed collection of information, “Current Good Manufacturing Practices and Related R...

Info on IND Regs Sent to OMB

03/03/2015

Federal Register Notice: FDA’s proposed collection of information, “Investigational New Drug (IND) Regulations —...

Workshop on Dystrophin Protein Quantification in Tissue

03/03/2015

Federal Register Notice: FDA and NIH will co-sponsor a public scientific workshop 3/20 to discuss dystrophin protein quantificatio...

Workshop on Pediatric Neurocognitive Outcomes

03/03/2015

Federal Register Notice: CDER’s Division of Gastroenterology and Inborn Errors Products Division and Division of Pediatric a...

CBER Seeks Participants for Site Visit Program

02/17/2015

Federal Register Notice: CBER is inviting participants for its Regulatory Site Visit Training Program. It is intended to give CBER...

Guidance on Urinary Tract Infection Treatments

02/17/2015

Federal Register Notice: FDA is making available a guidance for industry entitled Complicated Urinary Tract Infections: Developing...

Clinical Research Associates Conference Planned

02/17/2015

Federal Register Notice: FDA will sponsor the following conference: Educational Conference co-sponsored with the Society of Clinic...